Keywords: roche, xeloda, sees, strong, ph, iii, data

Roche's Xeloda sees strong Ph III data

Article | 12 June 2006

Print This

Swiss drug major Roche says that results from the largest-ever Phase III study in advanced esophagogastric cancer, were presented at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in